Catalent Stock Five Year Return
Catalent fundamentals help investors to digest information that contributes to Catalent's financial success or failures. It also enables traders to predict the movement of Catalent Stock. The fundamental analysis module provides a way to measure Catalent's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Catalent stock.
Catalent |
Catalent Company Five Year Return Analysis
Catalent's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
CompetitionAccording to the company disclosure, Catalent has a Five Year Return of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Catalent Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Catalent's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Catalent could also be used in its relative valuation, which is a method of valuing Catalent by comparing valuation metrics of similar companies.Catalent is currently under evaluation in five year return category among its peers.
Catalent Fundamentals
Return On Equity | -0.11 | |||
Return On Asset | -0.0018 | |||
Profit Margin | (0.09) % | |||
Operating Margin | (0.07) % | |||
Current Valuation | 16.13 B | |||
Shares Outstanding | 181.51 M | |||
Shares Owned By Insiders | 0.50 % | |||
Shares Owned By Institutions | 87.80 % | |||
Number Of Shares Shorted | 14.74 M | |||
Price To Earning | 17.80 X | |||
Price To Book | 3.25 X | |||
Price To Sales | 2.61 X | |||
Revenue | 4.38 B | |||
Gross Profit | 1.04 B | |||
EBITDA | (284 M) | |||
Net Income | (1.04 B) | |||
Cash And Equivalents | 345 M | |||
Cash Per Share | 1.92 X | |||
Total Debt | 4.92 B | |||
Debt To Equity | 0.90 % | |||
Current Ratio | 2.86 X | |||
Book Value Per Share | 19.52 X | |||
Cash Flow From Operations | 268 M | |||
Short Ratio | 7.89 X | |||
Earnings Per Share | (2.28) X | |||
Price To Earnings To Growth | 529.00 X | |||
Target Price | 63.4 | |||
Number Of Employees | 17 K | |||
Beta | 1.16 | |||
Market Capitalization | 11.52 B | |||
Total Asset | 9.75 B | |||
Retained Earnings | (781 M) | |||
Working Capital | 1.57 B | |||
Current Asset | 790.2 M | |||
Current Liabilities | 391.2 M | |||
Net Asset | 9.75 B |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Catalent Stock
If you are still planning to invest in Catalent check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalent's history and understand the potential risks before investing.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |